Live Breaking News & Updates on Corticosteroids

Stay informed with the latest breaking news from Corticosteroids on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Corticosteroids and stay connected to the pulse of your community

Combination Therapies Optimize Hair Regrowth in Pediatric Patients With AA

Corticosteroids are the most common treatment for pediatric patients with alopecia areata (AA), but promising newer options like JAK inhibitors are emerging. This review highlights the importance of personalized treatment plans and maximizing response through combination therapies.

Image-credit , Alopecia-areata , Pediatric-patients , Corticosteroids , Treatment-therapy ,

Anti-VEGF Treatment Provides Long-Term Treatment in Diabetic Macular Edema

Although corticosteroids were found to immediately improve best-corrected visual acuity and central macular thickness, anti–vascular endothelial growth factor (anti-VEGF) therapies had significant long-term advantages when treating diabetic macular edema.

Liudmila-dutko , Cochrane-library , Anti-vegf , Dme , Corticosteroids , Treatment ,

Study Finds Significant Hair Regrowth in Patients With Patchy AA Following Baricitinib Treatment

Baricitinib was found to be an effective treatment for patchy alopecia areata (AA), in a retrospective study, with most patients experiencing hair regrowth after 4 to 16 weeks of treatment.

Image-credit , Alopecia-tool , Alopecia-areata , Baricitinib , Treatment , Hair-regrowth , Patchy-aa , Olumiant , Ema , Janus-kinase-inhibitors , Inflammatory-diseases

Corticosteroids Induce Remission in Patients With IgA Nephropathy, Moderate Proteinuria

Patients with IgAN and urine protein levels of 0.75–3.5 g/d treated with corticosteroids exhibited significantly greater overall and complete remission rates compared to those who received supportive care.

Yu-wang , Henan , China , National-institutes-of-health , First-hospital-of-sun-yat-sen-university , Sun-yat-sen-university , First-hospital , Sun-yat-sen , Iga-nephropathy , Berger-disease , Igan

Belimumab Linked to Long-Term Corticosteroid Reduction in Patients with Lupus

A retrospective cohort analysis suggests the monoclonal antibody may help patients with SLE reduce their reliance on oral corticosteroids over 1 year after initiating treatment.

Linkedin-karen-worley , Karen-worley , Drug-administration , Patient-important-outcomes-data-repository , Sle , Lupus , Corticosteroids , Ocs , Belimumab , Treatment , Gsk , Benefit

Etrasimod Significantly Benefits Ulcerative Colitis Regardless of Corticosteroids

New data from ACG 2023 shows etrasimod-treated patients were able to achieve UC remission, with or without concomitant steroid treatment at baseline.

Vancouver , British-columbia , Canada , Brucee-sands , Icahn-school-of-medicine-at-mount-sinai , American-college-of-gastroenterology , American-college , Scientific-meeting , Icahn-school , Mount-sinai , Etrasimod